Cargando…
GB-2 blocking the interaction between ACE2 and wild type and mutation of spike protein of SARS-CoV-2
Since the start of the outbreak of coronavirus disease 2019 in Wuhan, China, there have been more than 150 million confirmed cases of the disease reported to the World Health Organization. The beta variant (B.1.351 lineage), the mutation lineages of SARS-CoV-2, had increase transmissibility and resi...
Autores principales: | Tsai, Ming-Shao, Yang, Yao-Hsu, Lin, Yu-Shih, Chang, Geng-He, Hsu, Cheng-Ming, Yeh, Reming-Albert, Shu, Li-Hsin, Cheng, Yu-Ching, Liu, Hung-Te, Wu, Yu-Huei, Wu, Yu-Heng, Shen, Rou-Chen, Wu, Ching-Yuan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Authors. Published by Elsevier Masson SAS.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8339502/ https://www.ncbi.nlm.nih.gov/pubmed/34388530 http://dx.doi.org/10.1016/j.biopha.2021.112011 |
Ejemplares similares
-
Potential inhibitor for blocking binding between ACE2 and SARS-CoV-2 spike protein with mutations
por: Tsai, Ming-Shao, et al.
Publicado: (2022) -
GB-2 inhibits ACE2 and TMPRSS2 expression: In vivo and in vitro studies
por: Wu, Ching-Yuan, et al.
Publicado: (2020) -
The anti-SARS-CoV-2 effect and mechanism of Chiehyuan herbal oral protection solution
por: Wu, Ching-Yuan, et al.
Publicado: (2023) -
SARS‐CoV‐2 spike protein enhances MAP4K3/GLK‐induced ACE2 stability in COVID‐19
por: Chuang, Huai‐Chia, et al.
Publicado: (2022) -
Danshen Improves Survival of Patients With Breast Cancer and Dihydroisotanshinone I Induces Ferroptosis and Apoptosis of Breast Cancer Cells
por: Lin, Yu-Shih, et al.
Publicado: (2019)